🇪🇺 BNT162b2 (Omi JN.1) in European Union

BNT162b2 (Omi JN.1) (bnt162b2-omi-jn-1) regulatory status in European Union.

Marketing authorisation

EMA

  • Status: approved

BNT162b2 (Omi JN.1) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in European Union

Frequently asked questions

Is BNT162b2 (Omi JN.1) approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for BNT162b2 (Omi JN.1) in European Union?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.